Latest Analyst Reports On Alliqua Inc
Recently stock market analysts have updated their consensus ratings on shares of Alliqua Inc (ALQA).
Most recent broker ratings
02/24/2016 – Alliqua Inc had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 3 price target on the stock.
02/24/2016 – Alliqua Inc had its “buy” rating reiterated by analysts at Chardan Capital. They now have a USD 2.25 price target on the stock.
11/02/2015 – Alliqua Inc had its “buy” rating reiterated by analysts at H.C. Wainwright. They now have a USD 10 price target on the stock.
06/26/2015 – Cowen began new coverage on Alliqua Inc giving the company a “outperform” rating. They now have a USD 9 price target on the stock.
05/19/2015 – Alliqua Inc was upgraded to “buy” by analysts at Zacks. They now have a USD 4.75 price target on the stock.
02/24/2015 – Alliqua Inc had its “outperform” rating reiterated by analysts at Northland Securities. They now have a USD 8 price target on the stock.
11/20/2014 – Craig-Hallum began new coverage on Alliqua Inc giving the company a “buy” rating.
06/04/2014 – Ascendiant Capital Markets began new coverage on Alliqua Inc giving the company a “buy” rating. They now have a USD 9 price target on the stock.
12/09/2013 – Summer Street began new coverage on Alliqua Inc giving the company a “buy” rating. They now have a USD 10 price target on the stock.
12/09/2013 – Alere Financial began new coverage on Alliqua Inc giving the company a “buy” rating. They now have a USD 10 price target on the stock.
Alliqua Inc has a 50 day moving average of 0.83 and a 200 day moving average of 1.73. The stock’s market capitalization is 24.90M, it has a 52-week low of 0.70 and a 52-week high of 5.66.
The share price of the company (ALQA) was down -3.74%, with a high of 0.94 during the day and the volume of Alliqua Inc shares traded was 61804.
View other investors thoughts on Alliqua Inc with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.

